Materiały źródłowe

• #1 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Treatment most often involves medicines to help ease your symptoms. It’s common to get the condition again, called a relapse. […] A low dose of a corticosteroid you take by mouth, such as prednisone, most often treats polymyalgia rheumatica. You may feel rapid relief from pain and stiffness in 1 to 3 days. […] After 2 to 4 weeks of treatment, your healthcare professional might start to lower your dosage slowly. This depends on your symptoms and the results of blood tests. Because corticosteroids have side effects, the goal is to have you take the lowest dose that keeps symptoms from coming back. […] Many people with polymyalgia rheumatica need to have the corticosteroid treatment for 1 to 2 years or more. You have follow-up visits with your healthcare team often. This is to see how the treatment is working and to watch for side effects.

• #2

  https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

  Steroid medicine is the main treatment for polymyalgia rheumatica (PMR). […] A type of steroid called prednisolone is usually prescribed. […] Prednisolone works by blocking the effects of certain chemicals that cause inflammation inside your body. It does not cure polymyalgia rheumatica, but it can help relieve the symptoms. […] When used to treat polymyalgia rheumatica, prednisolone is taken as a tablet. Most people will be prescribed several tablets to take once a day. […] To start with, you may be prescribed a moderate dose of prednisolone. The dose will usually be reduced gradually every 1 to 2 months if you are responding well to treatment and your symptoms are well controlled. […] Although your symptoms should improve within a few days of starting treatment, you’ll probably need to continue taking a low dose of prednisolone for about 2 years.

• #3 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  Polymyalgia rheumatica (PMR) is a chronic, self-limited disorder. Therapy is based on empiric experiences because few randomized clinical trials are available to guide treatment decisions. The therapeutic goals are to control painful myalgia, to improve muscle stiffness, and to resolve constitutional features of the disease. […] Corticosteroids (ie, prednisone) are considered the treatment of choice because they often produce complete or near-complete symptom resolution and reduction of inflammatory markers (erythrocyte sedimentation rate [ESR] or C-reactive protein [CPR] level) to normal. However, no definite evidence demonstrates that corticosteroids (or any other therapy) alter the natural history of PMR. […] Joint guidelines from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) conditionally recommend starting corticosteroid therapy with 12.5-25 mg/day of prednisone or the equivalent.

• #4 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative | Annals of the Rheumatic Diseases

  https://ard.bmj.com/content/74/10/1799

  These recommendations will inform primary, secondary and tertiary care physicians about an international consensus on the management of PMR. […] These recommendations should serve to inform clinicians about best practices in the care of patients with PMR. […] The panel strongly recommends using GC instead of NSAIDs in patients with PMR, with the exception of possible short-term use of NSAIDs and/or analgesics in PMR patients with pain related to other conditions. […] The panel strongly recommends using the minimum effective individualised duration of GC therapy in PMR patients. […] The panel conditionally recommends using the minimum effective GC dose within a range of 12.5-25mg prednisone equivalent daily as the initial treatment of PMR. […] The panel strongly recommends individualising dose tapering schedules, predicated to regular monitoring of patient disease activity, laboratory markers and adverse events.

• #5 Treatment of polymyalgia rheumatica – UpToDate

  https://www.uptodate.com/contents/treatment-of-polymyalgia-rheumatica

  Treatment of polymyalgia rheumatica (PMR) will be reviewed here. […] Overall approach — Initial treatment with low-dose glucocorticoids is recommended for all patients diagnosed with polymyalgia rheumatica (PMR) (algorithm 1). The primary goal of treatment is the relief of symptoms. The initial dose of prednisone needed to alleviate musculoskeletal symptoms in PMR is lower than that used to control the vascular inflammation associated with giant cell arteritis (GCA). […] Though there are no randomized trials comparing prednisone or prednisolone with placebo or other single agents, the efficacy of glucocorticoids for the management of PMR has been established by decades of clinical experience and observational studies. The therapeutic response to low-dose prednisone or prednisolone is characteristically brisk and complete.

• #6 Polymyalgia rheumatica

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2287267/

  Polymyalgia rheumatica is treated with glucocorticosteroids, starting at 15 mg prednisone a day. […] Treatment with a moderate dose of prednisone 15 mg once daily in the morning can help confirm the diagnosis. […] The initial dose of prednisone is 15 mg a day, and it should be increased to no higher than 20 mg a day in the first week or two of treatment. […] Glucocorticosteroids are often needed for two to three years, although about 10% of patients will relapse within 10 years and require longer courses of treatment. […] The recommended dose of prednisone is the lowest dose that keeps symptoms in remission. […] Non-steroidal anti-inflammatory agents have little use in the management of polymyalgia rheumatica and are associated with considerable drug related morbidity. […] Other alternative and adjuvant glucocorticosteroid sparing treatments that have been suggested especially in refractory cases include methotrexate and anti-tumour necrosis factor agents.

• #7 Polymyalgia Rheumatica: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

  Polymyalgia rheumatica treatment begins with a low dose of corticosteroids. Your healthcare provider may recommend 10 mg (milligrams) to 15 mg per day of prednisone, which may rapidly relieve your pain and stiffness. If your symptoms improve, the steroid is gradually lessened over one to two years. In some instances, relapses may occur, and you may need a low dose of steroids long-term to prevent flares. Sometimes, other medications are needed to help control the inflammation and lower steroid dose. […] Researchers have studied other drugs for the treatment of polymyalgia rheumatica, including immunosuppressants like methotrexate, but the results were mixed. The U.S. Food and Drug Administration (FDA) approved a biologic medication called tocilizumab to treat giant cell arteritis and rheumatoid arthritis. But researchers need more data to determine if the drug is safe and effective for the treatment of polymyalgia rheumatica.

• #8 Polymyalgia rheumatica Information | Mount Sinai – New York

  https://www.mountsinai.org/health-library/diseases-conditions/polymyalgia-rheumatica

  Without treatment, PMR does not get better. However, low doses of corticosteroids (such as prednisone, 10 to 20 mg per day) can markedly ease symptoms, often within a day or two. […] The dose should then be slowly reduced to a very low level. […] Treatment needs to continue for 1 to 2 years. In some people, even longer treatment with low doses of prednisone is needed. […] Corticosteroids can cause many side effects such as weight gain, development of diabetes or osteoporosis. You need to be watched closely if you are taking these medicines. If you are at risk for osteoporosis, your health care provider may recommend you take medicines to prevent this condition.

• #9 What Is the Best Treatment for Polymyalgia Rheumatica? | AAFP

  https://www.aafp.org/pubs/afp/issues/2010/0315/p788.html

  Polymyalgia rheumatica is characterized by myalgias and morning stiffness in the shoulder and pelvic girdles and neck, in addition to low-grade fever, fatigue, and weight loss. The syndrome is usually treated with long-term corticosteroids, although other agents have also been used. […] The type of treatment regimen that was used varied considerably. Less than 1 percent of patients required prednisone or prednisolone at starting dosages above 15 mg per day to control symptoms. Relapses were more common if the initial dosage was 10 mg per day, whereas more than 15 mg per day had a greater risk of steroid-related adverse effects without additional benefit. Up to 50 percent of patients were able to discontinue steroid use within two years when the initial prednisone dosage was 10 to 20 mg per day. Fewer relapses occurred when steroid use was tapered slowly (e.g., less than 1 mg per month or 1 mg every two months). Intra-articular methylprednisolone (Depo-Medrol) showed some benefit, but the authors believed it should be reserved for patients at high risk of glucocorticoid-related adverse effects or when polymyalgia rheumatica was limited to the shoulder girdle.

• #10 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Treatment most often involves medicines to help ease your symptoms. It’s common to get the condition again, called a relapse. […] A low dose of a corticosteroid you take by mouth, such as prednisone, most often treats polymyalgia rheumatica. You may feel rapid relief from pain and stiffness in 1 to 3 days. […] After 2 to 4 weeks of treatment, your healthcare professional might start to lower your dosage slowly. This depends on your symptoms and the results of blood tests. Because corticosteroids have side effects, the goal is to have you take the lowest dose that keeps symptoms from coming back. […] Many people with polymyalgia rheumatica need to have the corticosteroid treatment for 1 to 2 years or more. You have follow-up visits with your healthcare team often. This is to see how the treatment is working and to watch for side effects.

• #11 Polymyalgia Rheumatica Treatment – Brigham and Women’s Hospital

  https://www.brighamandwomens.org/medicine/rheumatology-inflammation-immunity/arthritis-and-joint-diseases-center/polymyalgia-rheumatica

  If the diagnosis of PMR is strongly suspected, a trial of low dose steroids (glucocorticoids) is given, usually in the form of 10-15 mg of prednisone per day. […] If PMR is present, the response to steroids can be dramatic sometimes patients experience improvement after only one dose but sometimes the response is slower. […] If symptoms have not been completely relieved after 2 to 3 weeks of low dose steroids, the diagnosis of PMR must be questioned, and other diagnoses should be considered.

• #12 Polymyalgia rheumatica: An updated review | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/87/9/549

  Tapering should be individualized once remission is achieved. […] Induction dosing should be based on symptom severity, body mass index, and comorbidities. […] Treatment should have the goal of symptom remission, as well as improvement and eventual normalization of ESR and CRP levels. […] If improvements are not evident within 1 to 2 weeks of starting therapy, prednisone should be escalated and alternate diagnoses considered. […] Another debated issue is treatment duration, which should generally be patient-specific and symptom-driven. […] The glucocorticoid dosage that controls symptoms is typically maintained for 2 to 4 weeks after pain and stiffness have resolved. […] Once a daily prednisone dosage of 10 mg is reached, tapering should be slowed to a rate of 1 mg every 1 to 2 months until discontinuation.

• #13 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Treatment most often involves medicines to help ease your symptoms. It’s common to get the condition again, called a relapse. […] A low dose of a corticosteroid you take by mouth, such as prednisone, most often treats polymyalgia rheumatica. You may feel rapid relief from pain and stiffness in 1 to 3 days. […] After 2 to 4 weeks of treatment, your healthcare professional might start to lower your dosage slowly. This depends on your symptoms and the results of blood tests. Because corticosteroids have side effects, the goal is to have you take the lowest dose that keeps symptoms from coming back. […] Many people with polymyalgia rheumatica need to have the corticosteroid treatment for 1 to 2 years or more. You have follow-up visits with your healthcare team often. This is to see how the treatment is working and to watch for side effects.

• #14 Treatment – GPnotebook

  https://gpnotebook.com/en-IE/pages/general-practice/polymyalgia-rheumatica/treatment

  Steroid therapy for polymyalgia rheumatica should make the patient feel better within days rather than weeks. […] British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guidelines recommend initiation of low-dose steroid therapy with gradually tailored tapering in straightforward PMR. […] the suggested regimen is daily prednisolone 15 mg for 3 weeks, then 12.5 mg for 3 weeks, then 10 mg for 46 weeks, then reduction by 1 mg every 48 weeks or alternate day reductions (e.g. 10/7.5 mg alternate days, etc.). […] this recommendation should be flexible and tailored to the individual as there is heterogeneity in disease course. […] adjustments of the steroid dose may be necessary according to the disease severity, comorbidity, side effects and patient’s wishes.

• #15 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  A slow tapering of the prednisone, less than 1 mg/month, was associated with fewer relapses. […] The corticosteroid dose should be increased if symptoms are not well controlled within 1 week, and a diagnosis of giant cell arteritis may need to be pursued, especially if prednisone 20 mg/d does not control symptoms. […] Tapering should be guided by clinical response to include decreased pain and stiffness, decreased morning stiffness, and decreased shoulder pain/limitation on clinical examination. […] Sarilumab (Kevzara), an interleukin-6 receptor inhibitor, was approved by the US Food and Drug Administration (FDA) in February 2023 for adults with PMR. It is the first biologic treatment approved for this disease. […] Limited but increasing data on tocilizumab, an interleukin-6 receptor antagonist, suggest that this agent is effective, safe, and well tolerated in patients with PMR and has a robust steroid-sparing effect.

• #16 What Is the Best Treatment for Polymyalgia Rheumatica? | AAFP

  https://www.aafp.org/pubs/afp/issues/2010/0315/p788.html

  Polymyalgia rheumatica is characterized by myalgias and morning stiffness in the shoulder and pelvic girdles and neck, in addition to low-grade fever, fatigue, and weight loss. The syndrome is usually treated with long-term corticosteroids, although other agents have also been used. […] The type of treatment regimen that was used varied considerably. Less than 1 percent of patients required prednisone or prednisolone at starting dosages above 15 mg per day to control symptoms. Relapses were more common if the initial dosage was 10 mg per day, whereas more than 15 mg per day had a greater risk of steroid-related adverse effects without additional benefit. Up to 50 percent of patients were able to discontinue steroid use within two years when the initial prednisone dosage was 10 to 20 mg per day. Fewer relapses occurred when steroid use was tapered slowly (e.g., less than 1 mg per month or 1 mg every two months). Intra-articular methylprednisolone (Depo-Medrol) showed some benefit, but the authors believed it should be reserved for patients at high risk of glucocorticoid-related adverse effects or when polymyalgia rheumatica was limited to the shoulder girdle.

• #17

  https://www.nhs.uk/conditions/polymyalgia-rheumatica/

  A steroid medicine called prednisolone is the main treatment for polymyalgia rheumatica. It’s used to help relieve the symptoms. […] To start with, you may be prescribed a moderate dose of prednisolone, which will be gradually reduced over time. […] Most people with polymyalgia rheumatica will need a course of steroid treatment that lasts for 12 months to 2 years to prevent their symptoms returning.

• #18 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Treatment most often involves medicines to help ease your symptoms. It’s common to get the condition again, called a relapse. […] A low dose of a corticosteroid you take by mouth, such as prednisone, most often treats polymyalgia rheumatica. You may feel rapid relief from pain and stiffness in 1 to 3 days. […] After 2 to 4 weeks of treatment, your healthcare professional might start to lower your dosage slowly. This depends on your symptoms and the results of blood tests. Because corticosteroids have side effects, the goal is to have you take the lowest dose that keeps symptoms from coming back. […] Many people with polymyalgia rheumatica need to have the corticosteroid treatment for 1 to 2 years or more. You have follow-up visits with your healthcare team often. This is to see how the treatment is working and to watch for side effects.

• #19 Polymyalgia rheumatica (PMR) | Causes, symptoms, treatments

  https://versusarthritis.org/about-arthritis/conditions/polymyalgia-rheumatica-pmr/

  Guidelines setting out the best treatment and care for people with polymyalgia rheumatica state there should be shared decision making between a patient and their healthcare professionals. […] If you have this condition, you should have a treatment plan tailored to you, that includes: initial dose of steroids and a schedule for when this dose will ideally be reduced and by how much, if your condition remains under control. […] Steroid treatment is usually very effective to treat polymyalgia rheumatica. […] Steroids work by reducing inflammation. They cant cure your condition, but the symptoms will improve significantly within two weeks once steroid treatment is started. […] Normally, steroid treatment for polymyalgia rheumatica will be taken as tablets. […] Your symptoms may almost disappear after four weeks of steroid treatment. However, treatment usually needs to continue for up to two years, or occasionally longer, to stop the symptoms returning.

• #20 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  If not contraindicated, NSAIDs may provide supplemental pain relief. […] Other corticosteroid-sparing agents (eg, methotrexate) are sometimes considered in patients with PMR to reduce corticosteroid-related adverse effects, especially in certain patient populations, such as diabetic patients or in those who develop osteonecrosis. […] Patients receiving steroids should have monthly follow-up, with regular monitoring of inflammatory markers. […] A baseline bone mineral density study (eg, dual-energy x-ray absorptiometry [DEXA] scan) is recommended at the onset of treatment. […] Approximately 50-75% of patients can discontinue corticosteroid therapy after 2 years of treatment. However, some patients may require low doses of corticosteroids for several years.

• #21

  https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

  Polymyalgia rheumatica often improves on its own after this time. However, there’s a chance it will return after treatment stops. This is known as a relapse. […] Sometimes other medicines may be combined with corticosteroids to help prevent relapses or allow your dose of prednisolone to be reduced. […] Some people are prescribed immunosuppressant medicine, such as methotrexate. It’s used to suppress the immune system, the body’s defence against infection and illness. […] It may help people with polymyalgia rheumatica who have frequent relapses or do not respond to normal steroid treatment. […] Your doctor may recommend painkillers, such as paracetamol to help relieve your pain and stiffness while your dose of prednisolone is reduced.

• #22 Polymyalgia rheumatica (PMR) | Causes, symptoms, treatments

  https://versusarthritis.org/about-arthritis/conditions/polymyalgia-rheumatica-pmr/

  The steroid tablet most often prescribed is called prednisolone. […] Potential side effects can include weight gain and the condition osteoporosis, which can cause peoples bones to become thinner and more fragile, and therefore may fracture more easily. […] After two to four weeks, your doctor will gradually reduce the dose of steroids. […] If symptoms return when the dose is reduced, your doctor may have to increase the dose for a short time, possibly several weeks, and then try to reduce it again. […] You shouldnt stop taking your steroid tablets suddenly or alter the dose unless advised by your doctor, even if your symptoms have completely cleared up. […] Like all medicines, steroids can have side effects. One of the side effects of steroids is osteoporosis, which can cause bones to become thinner and then fracture.

• #23 Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review | BMC Rheumatology | Full Text

  https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-024-00422-6

  In cases of relapse, we recommend increasing the GC dose to the pre-relapse dose, followed by gradual tapering (within 48 weeks) to the dose at which the relapse occurred. […] Methotrexate (MTX) 10-20 mg once a week, in addition to GCs, should be considered early in patients with comorbidities that may be exacerbated by GC therapy. […] It is crucial to ensure that everyone diagnosed with PMR is aware of the link between PMR and GCA. […] Patients should be followed closely after starting GC treatment. We recommend a follow-up visit at 24 weeks and 3, 6, 9, and 12 months after commencing GCs as a minimum in newly diagnosed patients.

• #24

  https://bpac.org.nz/2023/pmr.aspx

  For patients who require an alternative to corticosteroids, treatment decisions should be made following consultation with a rheumatologist; methotrexate is an option. […] A trial of an oral corticosteroid can be initiated for patients with suspected PMR once other diagnoses have been excluded and laboratory results (e.g. CRP and/or ESR) are available; prednisone is generally recommended. […] Patients generally respond rapidly to 15-20 mg of prednisone per day and can begin tapering the dose after symptoms have resolved, usually after two to four weeks. […] If tapering is difficult or if the dose cannot be decreased to 10 mg/day, discuss with or refer the patient to a rheumatologist. […] After two relapses, an alternative treatment (usually oral methotrexate, 10-20 mg in practice, once weekly; unapproved indication) may be considered in consultation with a rheumatologist.

• #25 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Long-term use of corticosteroids can result in serious side effects. These may include weight gain, bone thinning, high blood pressure, diabetes and cloudy areas on your eyes that can lead to vision loss, called cataracts. […] You may take daily doses of calcium and vitamin D supplements to help prevent bone loss from corticosteroid treatment. The American College of Rheumatology suggests supplements of 1,000 to 1,200 milligrams of calcium and 600 to 800 international units of vitamin D for anyone taking corticosteroids for three months or more. […] Guidelines from the American College of Rheumatology and the European League Against Rheumatism suggest using methotrexate with corticosteroids in some people. This is to lower the dose of corticosteroids or for relapses. […] The U.S. Food and Drug Administration has approved this medicine for people whose symptoms return. This medicine works by blocking a substance in the body that causes inflammation. You take this medicine as a shot every two weeks. It may relieve symptoms with a lower dose of corticosteroids.

• #26 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Long-term use of corticosteroids can result in serious side effects. These may include weight gain, bone thinning, high blood pressure, diabetes and cloudy areas on your eyes that can lead to vision loss, called cataracts. […] You may take daily doses of calcium and vitamin D supplements to help prevent bone loss from corticosteroid treatment. The American College of Rheumatology suggests supplements of 1,000 to 1,200 milligrams of calcium and 600 to 800 international units of vitamin D for anyone taking corticosteroids for three months or more. […] Guidelines from the American College of Rheumatology and the European League Against Rheumatism suggest using methotrexate with corticosteroids in some people. This is to lower the dose of corticosteroids or for relapses. […] The U.S. Food and Drug Administration has approved this medicine for people whose symptoms return. This medicine works by blocking a substance in the body that causes inflammation. You take this medicine as a shot every two weeks. It may relieve symptoms with a lower dose of corticosteroids.

• #27 Polymyalgia Rheumatica: Symptoms, Tests, and Treatment

  https://www.healthline.com/health/polymyalgia-rheumatica

  Theres no cure for polymyalgia rheumatica. But with the proper treatment, symptoms can improve in as little as 24 to 48 hours. Your doctor will prescribe a low-dose corticosteroid, such as prednisone, to help reduce inflammation. […] The typical dosage is 10 to 30 milligrams per day. Over-the-counter pain medications, such as ibuprofen and naproxen, arent usually effective in treating the symptoms of polymyalgia rheumatica. […] Although corticosteroids are effective in treating polymyalgia rheumatica, these drugs do have side effects. Long-term use of these medications increases your risk for: high blood pressure, high cholesterol, depression, weight gain, diabetes, osteoporosis, cataracts. […] To reduce your risk for developing side effects during treatment, your doctor may recommend that you take a daily calcium and vitamin D supplement.

• #28 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Long-term use of corticosteroids can result in serious side effects. These may include weight gain, bone thinning, high blood pressure, diabetes and cloudy areas on your eyes that can lead to vision loss, called cataracts. […] You may take daily doses of calcium and vitamin D supplements to help prevent bone loss from corticosteroid treatment. The American College of Rheumatology suggests supplements of 1,000 to 1,200 milligrams of calcium and 600 to 800 international units of vitamin D for anyone taking corticosteroids for three months or more. […] Guidelines from the American College of Rheumatology and the European League Against Rheumatism suggest using methotrexate with corticosteroids in some people. This is to lower the dose of corticosteroids or for relapses. […] The U.S. Food and Drug Administration has approved this medicine for people whose symptoms return. This medicine works by blocking a substance in the body that causes inflammation. You take this medicine as a shot every two weeks. It may relieve symptoms with a lower dose of corticosteroids.

• #29 Polymyalgia rheumatica: clinical update

  https://www.racgp.org.au/afp/2014/june/polymyalgia-rheumatica

  It is recommended that clinicians assess bone mineral density (BMD) before initiating corticosteroid treatment, which is likely to last longer than 3 months. The following steps should be taken at the commencement of steroid therapy: start adequate supplementation of calcium (1200 mg/day) and vitamin D3 (cholecalciferol, 800 IU/day); assess lumber and hip spine BMD; If BMD T-score is 1.5 or less consider an oral bisphosphonate such as alendronate (70 mg/week) or risedronate sodium (35 mg/week). […] PMR has an excellent prognosis with prompt diagnosis and adequate therapy. A trial of corticosteroids is not an alternative diagnostic test as it may be misleading because of a non-specific response.

• #30 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  If not contraindicated, NSAIDs may provide supplemental pain relief. […] Other corticosteroid-sparing agents (eg, methotrexate) are sometimes considered in patients with PMR to reduce corticosteroid-related adverse effects, especially in certain patient populations, such as diabetic patients or in those who develop osteonecrosis. […] Patients receiving steroids should have monthly follow-up, with regular monitoring of inflammatory markers. […] A baseline bone mineral density study (eg, dual-energy x-ray absorptiometry [DEXA] scan) is recommended at the onset of treatment. […] Approximately 50-75% of patients can discontinue corticosteroid therapy after 2 years of treatment. However, some patients may require low doses of corticosteroids for several years.

• #31

  https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

  Polymyalgia rheumatica often improves on its own after this time. However, there’s a chance it will return after treatment stops. This is known as a relapse. […] Sometimes other medicines may be combined with corticosteroids to help prevent relapses or allow your dose of prednisolone to be reduced. […] Some people are prescribed immunosuppressant medicine, such as methotrexate. It’s used to suppress the immune system, the body’s defence against infection and illness. […] It may help people with polymyalgia rheumatica who have frequent relapses or do not respond to normal steroid treatment. […] Your doctor may recommend painkillers, such as paracetamol to help relieve your pain and stiffness while your dose of prednisolone is reduced.

• #32 Polymyalgia rheumatica: An updated review | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/87/9/549

  For patients whose steroids were successfully discontinued before relapse, induction therapy should be restarted at the lowest effective dose with subsequent taper as tolerated. […] After 2 relapses, a steroid-sparing agent such as methotrexate, azathioprine, a TNF inhibitor, or an interleukin 6 (IL-6) receptor blocker can be tried. […] Methotrexate, usually at a starting dosage of 10 to 15 mg per week, is the most commonly used glucocorticoid-sparing therapy for PMR. […] The EULAR/ACR guidelines recommend the early introduction of methotrexate therapy in addition to glucocorticoids in patients at high risk for relapse or prolonged therapy and for those who develop glucocorticoid-related adverse effects. […] IL-6 blockade has been explored as a possible treatment, with promising results. […] Although data are still being accumulated, tocilizumab appears to be a promising glucocorticoid-sparing option for treating patients with PMR.

• #33 What Is the Best Treatment for Polymyalgia Rheumatica? | AAFP

  https://www.aafp.org/pubs/afp/issues/2010/0315/p788.html

  Oral and intramuscular methotrexate in a dosage of 10 mg per week had steroid-sparing effects and decreased relapse rates when added to prednisone therapy. […] The authors conclude that the current evidence suggests using prednisone or its equivalent at a starting dosage of 15 mg per day to control polymyalgia rheumatica activity in most patients. Slow tapering of steroid use is associated with fewer relapses and overall faster cessation of corticosteroid therapy. Of the steroid-sparing agents that were tested in this study, oral or intramuscular methotrexate added in dosages of at least 10 mg per week to prednisone therapy reduced the overall glucocorticoid requirement.

• #34

  https://bpac.org.nz/2023/pmr.aspx

  Disease modifying antirheumatic drugs (DMARDs), e.g. methotrexate, leflunomide, may be added to the corticosteroid regimen for some patients (e.g. those at high risk of relapse or after two relapses), or they can be used as an alternative if corticosteroids were ineffective, contraindicated or if significant adverse effects were experienced. […] There is evidence that biologic medicines, e.g. tocilizumab and sarilumab which inhibit interleukin-6 (a major driver of the CRP response), are an effective treatment for PMR allowing earlier reduction in dose and cessation of corticosteroids.

• #35 Methotrexate and Polymyalgia Rheumatica Therapy | AAFP

  https://www.aafp.org/pubs/afp/issues/2005/0901/p891.html

  Polymyalgia rheumatica, a syndrome characterized by proximal muscle pain and stiffness in older persons, generally is treated with prednisone (Deltasone). Dosages of 15 to 25 mg of prednisone per day can reduce inflammation considerably, although many patients relapse when therapy is tapered. Long-term (18 to 36 months) steroid treatment has been recommended by several studies, but this can result in multiple side effects, including osteoporosis, hypertension, cataracts, and hyperglycemia. […] The authors conclude that using prednisone and methotrexate together to treat polymyalgia rheumatica can decrease the number of flare-ups and reduce the total dosage of prednisone required to achieve and maintain remission. Considering the potential adverse effects of long-term prednisone therapy, this would be advantageous to all patients, especially those who cannot tolerate high doses of prednisone. Further studies are needed to determine whether methotrexate is effective as an induction therapy for polymyalgia rheumatica, and whether it can lower the initial dose of prednisone needed for treatment and control.

• #36 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  A slow tapering of the prednisone, less than 1 mg/month, was associated with fewer relapses. […] The corticosteroid dose should be increased if symptoms are not well controlled within 1 week, and a diagnosis of giant cell arteritis may need to be pursued, especially if prednisone 20 mg/d does not control symptoms. […] Tapering should be guided by clinical response to include decreased pain and stiffness, decreased morning stiffness, and decreased shoulder pain/limitation on clinical examination. […] Sarilumab (Kevzara), an interleukin-6 receptor inhibitor, was approved by the US Food and Drug Administration (FDA) in February 2023 for adults with PMR. It is the first biologic treatment approved for this disease. […] Limited but increasing data on tocilizumab, an interleukin-6 receptor antagonist, suggest that this agent is effective, safe, and well tolerated in patients with PMR and has a robust steroid-sparing effect.

• #37 Azthena logo with the word Azthena

  https://www.news-medical.net/news/20231025/Scientists-achieve-breakthrough-in-treating-neglected-polymyalgia-rheumatica.aspx

  Scientists have found success in treating a 'neglected’ inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients. […] The study, carried out by Anglia Ruskin University (ARU) and published in the New England Journal of Medicine, describes a successful trial of sarilumab. […] Our findings show promise that sarilumab could be used to treat PMR and improve outcomes for people tapering their steroid medication. […] This is an exciting development that has potential to improve treatment options in a condition that is common among older people. PMR is the most common reason for long-term steroid prescriptions. Any effective medication that can spare the use of steroids should have great impact on reducing the serious side effects of such steroids which can include diabetes, osteoporotic fractures and infections.

• #38 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Long-term use of corticosteroids can result in serious side effects. These may include weight gain, bone thinning, high blood pressure, diabetes and cloudy areas on your eyes that can lead to vision loss, called cataracts. […] You may take daily doses of calcium and vitamin D supplements to help prevent bone loss from corticosteroid treatment. The American College of Rheumatology suggests supplements of 1,000 to 1,200 milligrams of calcium and 600 to 800 international units of vitamin D for anyone taking corticosteroids for three months or more. […] Guidelines from the American College of Rheumatology and the European League Against Rheumatism suggest using methotrexate with corticosteroids in some people. This is to lower the dose of corticosteroids or for relapses. […] The U.S. Food and Drug Administration has approved this medicine for people whose symptoms return. This medicine works by blocking a substance in the body that causes inflammation. You take this medicine as a shot every two weeks. It may relieve symptoms with a lower dose of corticosteroids.

• #39 Polymyalgia Rheumatica | Arthritis Foundation

  https://www.arthritis.org/diseases/polymyalgia-rheumatica

  Because of the serious health risks of corticosteroids and because at least one-third of PMR patients taking it will relapse, researchers are constantly seeking better therapies. […] The first of these, a biologic medication called sarilumab (Kevzara), was approved by the FDA in 2023 for people with PMR who dont get enough relief from steroids. […] Sarilumab is called an interleukin-6 (IL-6) blocker because of how it works in the immune system. […] Another IL-6 blocker, tocilizumab (Actemra) is approved for giant cell arteritis.

• #40 Polymyalgia Rheumatica: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

  Polymyalgia rheumatica treatment begins with a low dose of corticosteroids. Your healthcare provider may recommend 10 mg (milligrams) to 15 mg per day of prednisone, which may rapidly relieve your pain and stiffness. If your symptoms improve, the steroid is gradually lessened over one to two years. In some instances, relapses may occur, and you may need a low dose of steroids long-term to prevent flares. Sometimes, other medications are needed to help control the inflammation and lower steroid dose. […] Researchers have studied other drugs for the treatment of polymyalgia rheumatica, including immunosuppressants like methotrexate, but the results were mixed. The U.S. Food and Drug Administration (FDA) approved a biologic medication called tocilizumab to treat giant cell arteritis and rheumatoid arthritis. But researchers need more data to determine if the drug is safe and effective for the treatment of polymyalgia rheumatica.

• #41 A new dawn for polymyalgia rheumatica: from diagnosis to emerging treatments | Medicine Today

  https://medicinetoday.com.au/mt/2024/jan-feb/feature-article/new-dawn-polymyalgia-rheumatica-diagnosis-emerging-treatments

  There has been little change in diagnostic and management approaches for polymyalgia rheumatica (PMR) since the 1950s. […] With recent US FDA approval of the first biologic agent for relapsing disease, modern medicine may soon become a reality for patients with PMR. […] Prednisolone remains the primary treatment, but recent studies have challenged the utility of traditional tapering strategies because of the development of persistent symptoms in many patients and long-term steroid-related risks. […] Steroid-sparing agents, including the biologic agents sarilumab, tocilizumab and rituximab, have shown promise in recent randomised clinical trials, potentially transforming the future of PMR management. […] Although prednisolone remains the mainstay of PMR treatment, increased recognition of a relapsing disease phenotype and greater appreciation of the risks associated with long-term low-dose glucocorticoid therapy have prompted a rethink of the current management paradigm to one that incorporates steroid-sparing agents and disease-modifying antirheumatic drugs (DMARDs).

• #42 How to Treat Refractory Polymyalgia Rheumatica – The Rheumatologist

  https://www.the-rheumatologist.org/article/how-to-treat-refractory-polymyalgia-rheumatica/

  Patients with polymyalgia rheumatica (PMR) who had relapsed while tapering glucocorticoid therapy were more likely to achieve sustained remission at one year and have a lower glucocorticoid exposure if they were treated with sarilumab (Kevzara) plus a rapid, 14-week glucocorticoid taper than if they received placebo plus a standard, 52-week glucocorticoid taper. […] There is a major unmet need for an effective corticosteroid-sparing strategy in this disease, particularly in refractory patients. […] Previous studies have implicated IL-6 in the pathophysiology of PMR and suggested that IL-6 inhibition may be clinically useful in treating the condition. […] The randomized, double-blind, placebo-controlled phase 3 SAPHYR trial was designed to assess the efficacy and safety of the IL-6 antagonist sarilumab in patients with PMR who had a disease flare while tapering glucocorticoid therapy.

• #43 Advances in the treatment of polymyalgia rheumatica and giant cell arteritis | Nature Reviews Rheumatology

  https://www.nature.com/articles/s41584-023-01069-2

  Research published in 2023 has demonstrated the efficacy of sarilumab for IL-6 blockade in polymyalgia rheumatica and of secukinumab for IL-17 blockade in giant cell arteritis (GCA). […] The safety and efficacy of sarilumab in patients with relapsing polymyalgia rheumatica was evaluated in the SAPHYR study, which demonstrated higher rates of sustained remission, lower rates of flares and less glucocorticoid exposure at 52 weeks in sarilumab-treated patients than in those treated with placebo. […] Inhibition of IL-17 with secukinumab is an emerging therapeutic option for giant cell arteritis (GCA) that is currently being explored in a phase 3 study after promising results of the phase 2 TitAIN trial, in which 70% of secukinumab-treated patients achieved the primary outcome of sustained remission at week 28, compared with 20% of the placebo group.

• #44 Polymyalgia rheumatica (PMR) | Causes, symptoms, treatments

  https://versusarthritis.org/about-arthritis/conditions/polymyalgia-rheumatica-pmr/

  The nationally recommended treatment for this is medicine called bisphosphonates. […] Painkillers, such as paracetamol, or short courses of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can help ease pain and stiffness. […] There may be some situations where your doctor will want to prescribe a type of drug called a disease-modifying anti-rheumatic drug (DMARD), alongside steroids. […] These drugs work by reducing inflammation that is causing symptoms such as pain and stiffness. […] DMARDs allow a lower dose of steroid to be used. […] You may need to see a specialist to be prescribed a DMARD. […] The specialist may decide to prescribe a DMARD alongside steroid tablets, which may help to reduce the inflammation and lower the steroid dose.

• #45 Polymyalgia rheumatica

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2287267/

  Polymyalgia rheumatica is treated with glucocorticosteroids, starting at 15 mg prednisone a day. […] Treatment with a moderate dose of prednisone 15 mg once daily in the morning can help confirm the diagnosis. […] The initial dose of prednisone is 15 mg a day, and it should be increased to no higher than 20 mg a day in the first week or two of treatment. […] Glucocorticosteroids are often needed for two to three years, although about 10% of patients will relapse within 10 years and require longer courses of treatment. […] The recommended dose of prednisone is the lowest dose that keeps symptoms in remission. […] Non-steroidal anti-inflammatory agents have little use in the management of polymyalgia rheumatica and are associated with considerable drug related morbidity. […] Other alternative and adjuvant glucocorticosteroid sparing treatments that have been suggested especially in refractory cases include methotrexate and anti-tumour necrosis factor agents.

• #46 Get Polymyalgia Rheumatica Treatment Online – TeleMed2U

  https://www.telemed2u.com/rheumatology/polymyalgia-rheumatica-pmr

  What are treatment options for polymyalgia rheumatica? […] Treatment for polymyalgia rheumatica is centered around managing a persons symptoms, which typically lasts around (6-9) months. Some treatment examples include: […] Nonsteroidal anti-inflammatory drugs (NSAIDs) – may be useful in milder cases of polymyalgia rheumatica but are usually ineffective treatment modalities for this condition. Both over the counter and prescription options may be used. […] Corticosteroids – usually the oral form of corticosteroid in low doses is used for the management of polymyalgia rheumatica. It helps to reduce inflammation and stiffness in the joints associated with this condition, and symptoms tend to respond fairly quickly once the medication is initiated. This medication is commonly used for about a year or more so close monitoring from your healthcare specialist will be needed.

• #47

  https://bpac.org.nz/2023/pmr.aspx

  Disease modifying antirheumatic drugs (DMARDs), e.g. methotrexate, leflunomide, may be added to the corticosteroid regimen for some patients (e.g. those at high risk of relapse or after two relapses), or they can be used as an alternative if corticosteroids were ineffective, contraindicated or if significant adverse effects were experienced. […] There is evidence that biologic medicines, e.g. tocilizumab and sarilumab which inhibit interleukin-6 (a major driver of the CRP response), are an effective treatment for PMR allowing earlier reduction in dose and cessation of corticosteroids.

• #48 Traditional and Emerging Strategies for Managing Polymyalgia Rheumatica: Insights into New Treatments

  https://www.mdpi.com/2077-0383/13/21/6492

  Polymyalgia Rheumatica (PMR) is an inflammatory condition that primarily affects individuals aged 50 and older, especially in Western countries. Although glucocorticoids are the cornerstone of PMR treatment, these drugs are associated with side effects, making it advisable to use them for the shortest duration possible. However, tapering or discontinuation of glucocorticoids often leads to disease relapses. In this review, we focus on the traditional management of PMR, as well as the potential for therapies that may reduce glucocorticoid use. Special attention is given to the efficacy of biologic agents in PMR management. […] Prednisone or prednisolone at a dose ranging between 12.5 and 25 mg/day is the agreed-upon treatment for PMR. Due to the side effects associated with prolonged glucocorticoid use and the high frequency of relapses when glucocorticoids are tapered, glucocorticoid-sparing agents have emerged as tools in the management of PMR. Methotrexate has traditionally been the conventional disease-modifying antirheumatic drug (DMARD) unanimously recommended for use in PMR. Other conventional DMARDs, such as leflunomide, have shown promising results but require further study. The use of biologic agents has marked a significant step forward in the management of PMR. While anti-TNF agents failed to provide beneficial effects in isolated PMR, anti-IL-6 receptor agents, such as tocilizumab and sarilumab, have demonstrated efficacy in reducing relapse frequency, lowering the cumulative glucocorticoid burden, and achieving long-term remission of the disease. Other biologic agents, many of which have been used in giant cell arteritis, as well as Janus kinase (JAK) inhibitors, are currently under investigation.

• #49

  https://www.nhs.uk/conditions/polymyalgia-rheumatica/treatment/

  Polymyalgia rheumatica often improves on its own after this time. However, there’s a chance it will return after treatment stops. This is known as a relapse. […] Sometimes other medicines may be combined with corticosteroids to help prevent relapses or allow your dose of prednisolone to be reduced. […] Some people are prescribed immunosuppressant medicine, such as methotrexate. It’s used to suppress the immune system, the body’s defence against infection and illness. […] It may help people with polymyalgia rheumatica who have frequent relapses or do not respond to normal steroid treatment. […] Your doctor may recommend painkillers, such as paracetamol to help relieve your pain and stiffness while your dose of prednisolone is reduced.

• #50 Polymyalgia Rheumatica: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/25215-polymyalgia-rheumatica

  Rest and exercise are also important factors in the treatment of polymyalgia rheumatica. Regular exercise can help you maintain muscle strength and joint flexibility. Good forms of exercise include riding a stationary bike, swimming, and walking. Your provider may also recommend physical therapy to help with discomfort and to maintain your mobility.

• #51 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Most people who take corticosteroids for polymyalgia rheumatica return to the level of activity they were at before they got the condition. But if you’ve had to limit your activity for a time, physical therapy may help. Talk with your healthcare team about whether physical therapy is a good choice for you.

• #52 Polymyalgia Rheumatica: Symptoms, Tests, and Treatment

  https://www.healthline.com/health/polymyalgia-rheumatica

  Your doctor may also suggest physical therapy to help improve your strength and increase your range of motion. […] Maintaining a healthy lifestyle can also help reduce the side effects of corticosteroids. Eating a balanced diet and limiting your salt intake can help prevent high blood pressure. Regular exercise can help strengthen your bones and muscles and prevent weight gain. […] Your doctor will carefully monitor your health during treatment. They may: order blood tests to check your cholesterol and blood sugar levels, recommend annual eye exams, schedule periodic bone density tests to check for signs of osteoporosis. […] Your doctor might also reduce your dosage after 3 or 4 weeks of treatment if your symptoms, including signs of inflammation, are improving. […] If your symptoms dont improve with medication, then polymyalgia rheumatica may not actually be the cause of your pain and stiffness. In this case, your doctor will run additional tests to check for other rheumatic disorders.

• #53 How to Thrive with Polymyalgia Rheumatica: Tips for Living Well with PMR – Overlake Arthritis and Osteoporosis Center

  https://www.overlakearthritis.com/how-to-thrive-with-polymyalgia-rheumatica-tips-for-living-well-with-pmr/

  Polymyalgia Rheumatica (PMR) is a relatively common inflammatory condition that primarily affects older adults, typically those over the age of 50, although it can occur at a younger age. […] While there is no cure for PMR, there are several strategies you can adopt to help manage your symptoms and thrive in your daily life. […] Consult with a rheumatologist or other specialists who can help diagnose and manage your PMR. Follow your doctors treatment plan, which may include medications like corticosteroids (prednisone) to reduce inflammation. Your Physician will also discuss with you a plan to slowly decrease the prednisone once your symptoms are under control. […] Its important to take the medications prescribed by your healthcare provider exactly as directed. […] Applying heat, such as warm baths or heating pads, can help ease muscle stiffness by increasing blood flow to select areas. Cold packs may help reduce inflammation, swelling and provide pain relief.

• #54 Polymyalgia Rheumatica

  https://www.physio.co.uk/what-we-treat/rheumatology/polymyalgia-rheumatica.php

  Polymyalgia rheumatica is a condition which causes inflammation and pain in a number of joints. Physiotherapy is an effective way to minimise the symptoms of polymyalgia rheumatica and Physio.co.uk have specialist physiotherapists that are experienced in treating the condition. […] If a diagnosis of polymyalgia rheumatica is confirmed, it is important that you begin physiotherapy as soon as possible to maximise your potential. The physiotherapists at Physio.co.uk will provide you with a full assessment which will then help them design an individualised treatment programme to meet your needs. […] Physiotherapy will help manage the symptoms of polymyalgia rheumatica in a number of different ways. All treatment programmes created by Physio.co.uk for polymyalgia rheumatica vary as each one will be personal to the individual. Physiotherapy can benefit polymyalgia rheumatica by: Improving range of movement, Reducing pain, Increasing cardiovascular levels, Allowing you to return to your normal activities of daily living/sports, Increasing muscle strength, Reducing symptoms of anxiety and depression, Maintaining a healthy weight, Reducing stiffness.

• #55 A Complementary and Integrative Medicine Approach to Polymyalgia Rheumatica: Testing and Treatment Options

  https://www.rupahealth.com/post/complementary-and-integrative-medicine-approach-to-polymyalgia-rheumatica-testing-and-treatment-options

  Complementary and integrative medicine can be used to help balance the inflammation involved in PMR, manage pain, and improve quality of life. Diet and lifestyle approaches like an anti-inflammatory diet and balanced exercise can help manage this rheumatic condition. […] Dietary patterns high in ultra-processed foods and low in nutrient-dense foods like fruits, vegetables, whole grains, legumes, olive oil, and oily fish tend to promote low-grade chronic inflammation that may lead to conditions like PMR. On the other hand, an anti-inflammatory diet like the Mediterranean diet focuses on foods that may help manage inflammation. […] Low intake of omega-3 fatty acids is associated with chronic pain. Omega-3 fatty acids from supplements or found in salmon, walnuts, flax seeds, chia seeds, and leafy greens may help balance immune system responses to inflammation, improve pain levels, and support against a recurrence of PMR.

• #56 A Complementary and Integrative Medicine Approach to Polymyalgia Rheumatica: Testing and Treatment Options

  https://www.rupahealth.com/post/complementary-and-integrative-medicine-approach-to-polymyalgia-rheumatica-testing-and-treatment-options

  Complementary and integrative medicine can be used to help balance the inflammation involved in PMR, manage pain, and improve quality of life. Diet and lifestyle approaches like an anti-inflammatory diet and balanced exercise can help manage this rheumatic condition. […] Dietary patterns high in ultra-processed foods and low in nutrient-dense foods like fruits, vegetables, whole grains, legumes, olive oil, and oily fish tend to promote low-grade chronic inflammation that may lead to conditions like PMR. On the other hand, an anti-inflammatory diet like the Mediterranean diet focuses on foods that may help manage inflammation. […] Low intake of omega-3 fatty acids is associated with chronic pain. Omega-3 fatty acids from supplements or found in salmon, walnuts, flax seeds, chia seeds, and leafy greens may help balance immune system responses to inflammation, improve pain levels, and support against a recurrence of PMR.

• #57 Polymyalgia Rheumatica Treatment: Medications, Physical Therapy, and Lifestyle Measures

  https://www.everydayhealth.com/rheumatic-diseases/managing-polymyalgia-rheumatica-treatment/

  If you develop high blood pressure or diabetes, your doctor may prescribe an additional medication or reevaluate your corticosteroid treatment. […] Depending on your risk level for osteoporosis, your doctor may also monitor your bone density and prescribe medications to safeguard your bone health. […] To help prevent bone loss, your doctor may prescribe calcium and vitamin D supplements along with your corticosteroids. […] Typical doses are 1,000 to 1,200 mg of calcium and 600 to 800 international units (IU) of vitamin D daily, according to Mayo Clinic. […] Mayo Clinic also notes that limiting sodium, including salt, in your diet may reduce fluid buildup and address high blood pressure linked to corticosteroid treatment. […] Talk to your doctor if you experience unpleasant symptoms or disruption in your life while youre taking corticosteroids, including any of the following issues, as identified by the Cleveland Clinic: Mood changes, Increased appetite or weight gain, Muscle weakness, Blurred vision, Bruising easily, Digestive upset, Difficulty sleeping.

• #58 Polymyalgia Rheumatica | HealthLink BC

  https://www.healthlinkbc.ca/healthwise/polymyalgia-rheumatica

  Your doctor may also suggest that you take medicine to help protect your digestive tract, such as a proton pump inhibitor or an H2 blocker. Taking medicines like steroids for a long time can irritate your esophagus and stomach and lead to ulcers. Proton pump inhibitors and H2 blockers help reduce this irritation. […] To protect your bones while you are being treated with steroid medicines: Be sure you get enough calcium and vitamin D. Calcium can help prevent bone thinning. Vitamin D helps your body absorb calcium. Ask your doctor if you need to take calcium and vitamin D supplements. Calcium supplements may interfere with your body’s ability to absorb biophosphonates. So take your calcium and vitamin D supplement at least 30 minutes after you take your bisphosphonate. Get regular weight-bearing exercise, such as walking, dancing, or weight lifting. This will help keep your bones strong and may also help your mood. Don’t smoke, and avoid being around tobacco smoke. Limit alcohol. It’s a good idea to have no more than one beer or one glass of wine each day.

• #59 Polymyalgia rheumatica | healthdirect

  https://www.healthdirect.gov.au/polymyalgia-rheumatica

  You may also be able to limit your symptoms by: eating a healthy diet. This can help you have better energy levels, feel better within yourself and achieve a healthy weight. […] exercising regularly. Low-impact activities such as swimming or walking can reduce your muscle pain and stiffness. […] learning new ways to manage your pain. Try different techniques until you find some that work for you. For example, heat packs help reduce muscle pain and cold packs can help reduce inflammation. […] For some people, polymyalgia rheumatica goes away with treatment and doesn’t come back. For others, polymyalgia rheumatica affects them for life.

• #60 How to Thrive with Polymyalgia Rheumatica: Tips for Living Well with PMR – Overlake Arthritis and Osteoporosis Center

  https://www.overlakearthritis.com/how-to-thrive-with-polymyalgia-rheumatica-tips-for-living-well-with-pmr/

  Polymyalgia Rheumatica (PMR) is a relatively common inflammatory condition that primarily affects older adults, typically those over the age of 50, although it can occur at a younger age. […] While there is no cure for PMR, there are several strategies you can adopt to help manage your symptoms and thrive in your daily life. […] Consult with a rheumatologist or other specialists who can help diagnose and manage your PMR. Follow your doctors treatment plan, which may include medications like corticosteroids (prednisone) to reduce inflammation. Your Physician will also discuss with you a plan to slowly decrease the prednisone once your symptoms are under control. […] Its important to take the medications prescribed by your healthcare provider exactly as directed. […] Applying heat, such as warm baths or heating pads, can help ease muscle stiffness by increasing blood flow to select areas. Cold packs may help reduce inflammation, swelling and provide pain relief.

• #61 Polymyalgia Rheumatica (PMR) Treatment & Management: Approach Considerations, Diet and Activity, Consultations and Long-Term Monitoring

  https://emedicine.medscape.com/article/330815-treatment

  If not contraindicated, NSAIDs may provide supplemental pain relief. […] Other corticosteroid-sparing agents (eg, methotrexate) are sometimes considered in patients with PMR to reduce corticosteroid-related adverse effects, especially in certain patient populations, such as diabetic patients or in those who develop osteonecrosis. […] Patients receiving steroids should have monthly follow-up, with regular monitoring of inflammatory markers. […] A baseline bone mineral density study (eg, dual-energy x-ray absorptiometry [DEXA] scan) is recommended at the onset of treatment. […] Approximately 50-75% of patients can discontinue corticosteroid therapy after 2 years of treatment. However, some patients may require low doses of corticosteroids for several years.

• #62 Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review | BMC Rheumatology | Full Text

  https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-024-00422-6

  In cases of relapse, we recommend increasing the GC dose to the pre-relapse dose, followed by gradual tapering (within 48 weeks) to the dose at which the relapse occurred. […] Methotrexate (MTX) 10-20 mg once a week, in addition to GCs, should be considered early in patients with comorbidities that may be exacerbated by GC therapy. […] It is crucial to ensure that everyone diagnosed with PMR is aware of the link between PMR and GCA. […] Patients should be followed closely after starting GC treatment. We recommend a follow-up visit at 24 weeks and 3, 6, 9, and 12 months after commencing GCs as a minimum in newly diagnosed patients.

• #63 Polymyalgia rheumatica

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2287267/

  It is important to tell patients about the small risk of disease recurrence at a later date in the form of giant cell arteritis without polymyalgia rheumatica. […] After the first few months of treatment, once the disease is controlled, asymptomatic patients with persistently raised inflammatory markers should not continue to be treated with high (or even higher) doses of prednisone just to reduce these markers. […] The core clinical response criteria include a reduction in the C reactive protein concentration or erythrocyte sedimentation rate (or both), improvement in morning stiffness, ability to raise the arms above shoulder height consistent with the patients baseline mobility before onset of polymyalgic symptoms, and improvement in the patients and doctors global assessment, preferably performed on a visual analogue scale.

• #64 Polymyalgia rheumatica

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2287267/

  It is important to tell patients about the small risk of disease recurrence at a later date in the form of giant cell arteritis without polymyalgia rheumatica. […] After the first few months of treatment, once the disease is controlled, asymptomatic patients with persistently raised inflammatory markers should not continue to be treated with high (or even higher) doses of prednisone just to reduce these markers. […] The core clinical response criteria include a reduction in the C reactive protein concentration or erythrocyte sedimentation rate (or both), improvement in morning stiffness, ability to raise the arms above shoulder height consistent with the patients baseline mobility before onset of polymyalgic symptoms, and improvement in the patients and doctors global assessment, preferably performed on a visual analogue scale.

• #65 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative | Annals of the Rheumatic Diseases

  https://ard.bmj.com/content/74/10/1799

  Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. […] In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. […] Eight overarching principles and nine specific recommendations were developed covering several aspects of PMR, including basic and follow-up investigations of patients under treatment, risk factor assessment, medical access for patients and specialist referral, treatment strategies such as initial glucocorticoid (GC) doses and subsequent tapering regimens, use of intramuscular GCs and disease modifying anti-rheumatic drugs (DMARDs), as well as the roles of non-steroidal anti-rheumatic drugs and non-pharmacological interventions.

• #66 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative | Annals of the Rheumatic Diseases

  https://ard.bmj.com/content/74/10/1799

  These recommendations will inform primary, secondary and tertiary care physicians about an international consensus on the management of PMR. […] These recommendations should serve to inform clinicians about best practices in the care of patients with PMR. […] The panel strongly recommends using GC instead of NSAIDs in patients with PMR, with the exception of possible short-term use of NSAIDs and/or analgesics in PMR patients with pain related to other conditions. […] The panel strongly recommends using the minimum effective individualised duration of GC therapy in PMR patients. […] The panel conditionally recommends using the minimum effective GC dose within a range of 12.5-25mg prednisone equivalent daily as the initial treatment of PMR. […] The panel strongly recommends individualising dose tapering schedules, predicated to regular monitoring of patient disease activity, laboratory markers and adverse events.

• #67 Polymyalgia rheumatica (PMR) | Causes, symptoms, treatments

  https://versusarthritis.org/about-arthritis/conditions/polymyalgia-rheumatica-pmr/

  Guidelines setting out the best treatment and care for people with polymyalgia rheumatica state there should be shared decision making between a patient and their healthcare professionals. […] If you have this condition, you should have a treatment plan tailored to you, that includes: initial dose of steroids and a schedule for when this dose will ideally be reduced and by how much, if your condition remains under control. […] Steroid treatment is usually very effective to treat polymyalgia rheumatica. […] Steroids work by reducing inflammation. They cant cure your condition, but the symptoms will improve significantly within two weeks once steroid treatment is started. […] Normally, steroid treatment for polymyalgia rheumatica will be taken as tablets. […] Your symptoms may almost disappear after four weeks of steroid treatment. However, treatment usually needs to continue for up to two years, or occasionally longer, to stop the symptoms returning.

• #68 Polymyalgia Rheumatica – Diagnosis & Management | POGO Physio Gold Coast

  https://www.pogophysio.com.au/blog/polymyalgia-rheumatica-diagnosis-management/

  PMR patients are generally diagnosed and treated within the primary care system, however should be considered for specialist referral if the patient presents with atypical features. […] Oral glucocorticoids (e.g. prednisolone) is the mainstay of PMR pharmacological treatment. Whilst effective, long term glucocorticoid use is associated with significant adverse effects, therefore most treatment involves an initial dosage to induce remission followed by a tapering period to avoid long term glucocorticoid exposure. […] The EULAR guidelines recommends prescription of an individualised exercise program with the goals being maintenance of muscle strength, function and falls prevention, particularly in eldery sufferers. […] Given the higher risk of osteoporosis in PMR patients, due to long term glucocorticoid use, resistance exercise should be considered to attempt to attenuate bone and muscle loss. […] Polymyalgia Rheumatica is primarily managed pharmacologically with glucocorticoids. Physiotherapy interventions can assist in maintaining strength, range of motion and improving function, as well as reducing side effects associated with long term glucocorticoid use.

• #69 Polymyalgia rheumatica – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/polymyalgia-rheumatica/diagnosis-treatment/drc-20376545

  Most people who take corticosteroids for polymyalgia rheumatica return to the level of activity they were at before they got the condition. But if you’ve had to limit your activity for a time, physical therapy may help. Talk with your healthcare team about whether physical therapy is a good choice for you.

• #70 Polymyalgia rheumatica – Arthritis New Zealand

  https://www.arthritis.org.nz/forms-of-arthritis/polymyalgia-rheumatica/

  The usual course of this disease is two to four years. Effective treatments are available and in most cases people recover completely. […] Corticosteroid treatment is very effective for polymyalgia rheumatica, usually relieving systems within 24 to 48 hours. Your doctor will monitor the dose and gradually reduce it until all symptoms disappear. The amount of time needed is different for each person. […] Non-steroidal anti-inflammatory drugs (NSAIDS) may be useful to relieve mild symptoms but are not as effective as corticosteroids. […] Exercise activity usually helps ease morning stiffness. Physiotherapy may be helpful to maintain mobility and reduce pain. […] A daily intake of 1500mg daily from food is recommended; Vitamin D supplements may also help. […] Seek support from an arthritis educator at Arthritis New Zealand, your doctor, pharmacist, rheumatologist, friends and family as you learn more about polymyalgia rheumatica and how to manage it.

Zobacz więcej